IL-15-dependent CD8+CD122+ T cells ameliorate experimental autoimmune encephalomyelitis by modulating IL-17 production by CD4+ T cells

European Journal of Immunology

Volumn 44, Issue 11, 2014, Pages 3330-3341

  Yu, Ping ^a   Bamford, Richard N ^b   Waldmann, Thomas A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Transponics   (United States)

Author keywords

CD8+CD122+ T cells; Experimental autoimmune encephalomyelitis; Interleukin 15; Interleukin 17; Multiple sclerosis

Indexed keywords

IL17A PROTEIN, MOUSE; IL2RB PROTEIN, MOUSE; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR BETA; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CYTOLOGY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MOUSE; NATURAL KILLER CELL; SECRETION (PROCESS); SIGNAL TRANSDUCTION; TH17 CELL; TRANSGENIC MOUSE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERLEUKIN-15; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; TH17 CELLS;

EID: 84916879284     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444675     Document Type: Article

References (50)

1. Bamford, R. N., Grant, A. J., Burton, J. D., Peters, C., Kurys, G., Goldman, C. K., Brennan, J. et al., The IL-2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 1994. 91: 4940-4944.
2. Waldmann, T. A. and Tagaya, Y., The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 1999. 17: 19-49.
3. Marks-Konczalik, J., Dubois, S., Losi, J. M., Sabzevari, H., Yamada, N., Feigenbaum, L., Waldmann, T. A. et al., IL-2 induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc. Natl. Acad. Sci. USA 2000. 97: 11445-11450.
4. Waldmann, T. A., The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 2006. 6: 595-601.
5. Fehniger, T. A. and Caligiuri, M. A., Interleukin 15: biology and relevance to human disease. Blood 2001. 97: 14-32.
6. Dubois, S., Mariner, J., Waldmann, T. A. and Tagaya, Y., IL-15R alpha recycles and presents IL-15 in trans to neighboring cells. Immunity 2002. 17: 537-547.
7. Blanco-Jerez, C., Plaza, J. F., Masjuan, J., Orensanz, L. M. and Alvarez-Cermeno, J. C., Increased levels of IL-15 mRNA in relapsing-remitting multiple sclerosis attacks. J. Neuroimmunol. 2002. 128: 90-94.
8. McInnes, I. B., Leung, B. P., Sturrock, R. D., Field, M. and Liew, F. Y., Interleukin-15 mediates T-cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat. Med. 1997. 3: 189-195.
9. Kirman, I. and Nielsen, O. H., Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 1996. 91: 1789-1794.
10. Liu, Z., Geboes, K., Colpaert, S., D'Haens, G. R., Rutgeerts, P. and Ceuppens, J. L., IL-15 is highly expressed in inflammatory bowel disease and regulates local T-cell-dependent cytokine production. J. Immunol. 2000. 164: 3608-3615.
11. Benhmed, M., Meresse, B., Arnulf, B., Barbe, U., Mention, J. J., Verkarre, V., Allez, M. et al., Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 2007. 132: 994-1008.
12. Yokoyama, S., Watanabe, N., Sato, N., Perera, P. Y., Filkoski, L., Tanaka, T., Miyasaka, M. et al., Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc. Natl. Acad. Sci. USA 2009. 106: 15849-15854.
13. Meresse, B., Curran, S. A., Ciszewski, C., Orbelyan, G., Setty, M., Bhagat, G., Lee, L. et al., Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 2006. 203: 1343-1355.
14. Chen, J., Feigenbaum, L., Awasthi, P., Butcher, D. O., Anver, M. R., Golubeva, Y. G., Bamford, R. et al., Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα. Proc. Natl. Acad. Sci. USA 2013. 110: 13534-13539.
15. Kuczyński, S., Winiarska, H., Abramczyk, M., Szczawinska, K., Wierusz-Wysocka, B. and Dworacka, M., IL-15 is elevated in serum patients with type 1-diabetes mellitus. Diabetes Res. Clin. Pract. 2005. 69: 231-236.
16. Kim, Y. S., Maslinski, W., Zheng, X. X., Stevens, A. C., Li, X. C., Tesch, G. H., Kelley, V. R. et al., Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fcγ2a protein blocks delayed-type hypersensitivity. J. Immunol. 1998. 160: 5742-5748.
17. Baslund, B., Tvede, N., Danneskiold-Samsoe, B., Larsson, P., Panayi, G., Petersen, J., Petersen, L. J. et al., Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis. Rheum. 2005. 52: 2686-2692.
18. Morris, J. C., Janik, J. E., White, J. D., Fleisher, T. A., Brown, M., Tsudo, M., Goldman, C. K. et al., Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia. Proc. Natl. Acad. Sci. USA 2006. 103: 401-406.
19. Steinman, L., Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996. 85: 299-302.
20. Kivisakk, P., Matusevicius, D., He, B., Soderstrom, M., Fredrikson, S. and Link, H., IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clin. Exp. Immunol. 1998. 111: 193-197.
21. Losy, J., Niezgoda, A. and Zaremba, J., IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis. Folia Neuropathol. 2002. 40: 151-153.
22. Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Ozenci, V., Fredrikson, S. and Link, H., Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 1999. 5: 101-104.
23. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. et al., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566-573.
24. Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N. and Mills, K. H., T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 2010. 162: 1-11.
25. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 2001. 166: 7579-7587.
26. + T cells in a model for multiple sclerosis. J. Exp. Med. 2001. 194: 669-676.
27. + regulatory T cells in the recovery from experimental autoimmune encephalomyelitis. J. Immunol. 2008. 180: 825-832.
28. Mangalam, A. K., Luckey, D., Giri, S., Smart, M., Pease, L. R., Rodriguez, M. and David, C. S., Two discreet subsets of CD8 T cells modulate PLP(91-110) induced EAE in HLA-DR3 transgenic mice. J. Autoimmun. 2012. 38: 344-353.
29. Tsudo, M., Kitamura, F. and Miyasaka, M., Characterization of the IL-2R1538; chain using 3 distinct monoclonal antibodies. Proc. Natl. Acad. Sci. USA 1989. 86: 1982-1986.
30. Waldmann, T. A., Conlon, K. C., Stewart, D. M., Worthy, T. A., Janik, J. E., Fleisher, T. A., Albert, P. S. et al., Phase 1 trial of IL-15 trans-presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood 2013. 121: 476-484.
31. Hakimi, J., Ha, V. C., Lin, P., Campbell, E., Gately, M. K., Tsudo, M., Payne, P. W. et al., Humanized Mikβ1, a humanized antibody to the IL-2Rβ chain that acts synergistically with humanized anti-TAC. J. Immunol. 1993. 151: 1075-1085.
32. Tanaka, T., Tsudo, M., Karasuyama, H., Kitamura, F., Kono, T., Hatakeyama, M., Taniguchi, T. et al., A novel monoclonal antibody against murine IL-2Rβ chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J. Immunol. 1991. 147: 2222-2228.
33. Vosshenrich, C. A., García-Ojeda, M. E., Samson-Villéger, S. I., Pasqualetto, V., Enault, L., Richard-, Le, Goff, O. et al., A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 2006. 7: 1217-1224.
34. bright natural killer-cells mediate immunomodulatory effects of IL-2R1537;-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. USA 2006. 103: 5941-5946.
35. + regulatory T cells in the maintenance of T-cell homeostasis. J. Exp. Med. 2004. 200: 1123-1134.
36. + T cells as regulatory versus memory T cells. J. Immunol. 2010. 185: 803-807.
37. + regulatory thymocytes. Blood 2003. 102: 4107-4114.
38. - T cells in an autoimmune disease model. J. Clin. Invest. 2003. 112: 1037-1048.
39. + T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc. Natl. Acad. Sci. USA 2011. 108: 2010-2015.
40. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M., Regulatory T cells and immune tolerance. Cell 2008. 133: 775-787.
41. Yu, P., Steel, J. C., Zhang, M., Morris, J. C. and Waldmann, T. A., Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model. Clin. Cancer. Res. 2010. 16: 6019-6028.
42. Yu, P., Steel, J. C., Zhang, M., Morris, J. C., Waitz, R., Fasso, M., Allison, J. P. et al., Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model. Proc. Natl. Acad. Sci. USA 2012. 109: 6187-6192.
43. + T-cell response to produce IL-17. Eur. J. Immunol. 2007. 37: 2744-2752.
44. Hayakawa, Y., Huntington, N. D., Nutt, S. L. and Smyth, M. J., Functional subsets of mouse natural killer cells. Immunol. Rev. 2006. 214: 47-55.
45. bright NK-cell population. Eur. J. Immunol. 2010. 40: 1428-1439.
46. Fu, B., Wang, F., Sun, R., Ling, B., Tian, Z. and Wei, H., CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology 2011. 133: 350-359.
47. + T cells expressing V1538;8 TCR: a role of the Qa-1 molecule. Immunity 1995. 2: 185-194.
48. - T-suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol. Rev. 2001. 182: 201-206.
49. + T cells. J. Immunol. 2005. 175: 7093-7097.
50. Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing IL-17. Nat. Immunol. 2005. 6: 1133-1141.